Form 8-K - Current report:
SEC Accession No. 0001157523-20-000188
Filing Date
2020-02-12
Accepted
2020-02-12 07:07:25
Documents
13
Period of Report
2020-02-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a52172044.htm   iXBRL 8-K 30426
2 EXHIBIT 99.1 a52172044ex99_1.htm EX-99.1 1161250
  Complete submission text file 0001157523-20-000188.txt   1398715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20200212.xsd EX-101.SCH 4198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20200212_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20200212_pre.xml EX-101.PRE 16832
10 EXTRACTED XBRL INSTANCE DOCUMENT a52172044_htm.xml XML 4471
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 20599694
SIC: 2834 Pharmaceutical Preparations